Angiolymphoid Hyperplasia with Eosinophilia

Angiolymphoid hyperplasia with eosinophilia (ALHE), also called epithelioid hemangioma, is a rare, benign vascular proliferation characterized by the growth of small blood vessels lined by plump, “epithelioid” endothelial cells, accompanied by an inflammatory infiltrate rich in lymphocytes and eosinophils. Patients typically present with pink to red-brown, dome-shaped papules or nodules, most often around the ears or scalp, although lesions can appear elsewhere on the head and neck NCBIWikipedia.

Under the microscope, ALHE lesions show a mixture of capillary-sized vessels and larger, irregular blood-filled spaces. The overlying skin may be thickened or ulcerated, while beneath, a dense infiltrate of lymphocytes and eosinophils forms around the vessels. Although the exact trigger is unknown, this pattern of vascular growth plus inflammation defines the condition PubMed.

Types

1. Papular Variant
This form presents as multiple small (<1 cm) papules that are often firm and clustered. It typically affects younger adults and may be pruritic or asymptomatic Wikipedia.

2. Nodular Variant
Nodular ALHE appears as larger (often 1–3 cm), deeper nodules that can mimic other soft-tissue tumors. These tend to be more persistent and may recur after partial removal PubMed.

3. Solitary vs. Multiple Lesions
Some patients have a single lesion, while others develop dozens of lesions over time. The multiplicity may reflect an underlying predisposition to vascular proliferation or repeated local triggers Wikipedia.

4. Dermal vs. Subcutaneous Depth
Lesions confined to the dermis often appear flatter and more superficial, whereas subcutaneous forms present as deeper, more mobile nodules. Depth can influence both appearance and preferred treatment approach PubMed.

5. Head-and-Neck vs. Extra-Cephalic Location
Over 85% of ALHE cases occur on the head or neck, especially around the ears. Rarely, lesions arise on the trunk or limbs, where they may be mistaken for other vascular tumors Wikipedia.

Potential Causes

Because ALHE’s pathogenesis remains uncertain, experts have proposed multiple, sometimes overlapping theories:

1. Idiopathic (Unknown)
   No clear trigger is identified in many cases, suggesting an inherently unstable vascular response in susceptible skin PubMed.

2. Reactive Vascular Hyperplasia
   Local trauma—such as an insect bite or minor injury—may trigger endothelial cell proliferation as part of an aberrant wound-healing process Wikipedia.

3. Arteriovenous Shunting
   Abnormal connections between arteries and veins can increase local blood flow and pressure, stimulating ectatic vessel formation characteristic of ALHE Wikipedia.

4. Hormonal Influence (Estrogen)
   Elevated estrogen levels have been implicated, given some cases arise or worsen during pregnancy or with oral contraceptive use Wikipedia.

5. Type I Hypersensitivity
   An allergic response may drive eosinophil infiltration, with mediators like IL-5 promoting both inflammation and endothelial proliferation PubMed.

6. Infectious Agents
   Viral or bacterial pathogens—particularly HIV or HHV-8—have been suggested as rare triggers in immunocompromised patients Wikipedia.

7. Lymphoproliferative Process
   Some evidence of T-cell clonality and association with peripheral T-cell lymphoma hints at a possible lymphoid neoplastic component PubMed.

8. IgG4-Related Disease Association
   ALHE shares features with IgG4-related skin disease in a subset of patients, suggesting an autoimmune mechanism Wikipedia.

9. Genetic Mutations
   Sporadic somatic mutations in vascular growth genes (e.g., TEK encoding TIE-2 receptor) may underlie uncontrolled endothelial growth PubMed.

10. Local Trauma from Venipuncture
    Case reports describe ALHE developing at sites of repeated injections or blood draws, reinforcing the trauma hypothesis PubMed.

11. Chronic Inflammation
    Persistent local inflammation—such as eczema or contact dermatitis—could create a microenvironment favoring vascular proliferation Wikipedia.

12. Environmental Exposures
    Chemical irritants or allergens in occupational settings have been speculated to trigger local vascular reactions PubMed.

13. Age-Related Vascular Changes
    Microvascular remodeling in middle age may predispose some skin sites to exuberant vessel growth Wikipedia.

14. Genetic Predisposition
    Familial clustering, though rare, suggests some individuals may inherit a tendency toward vascular hyperplasia PubMed.

15. Unknown Hemodynamic Factors
    Local temperature, pH shifts, or mechanical stress on small vessels may influence endothelial cell behavior, but remain theoretical Wikipedia.

Key Symptoms

1. Dermal Papules or Nodules
   Round to dome-shaped, pink to red-brown lesions, typically 0.5–3 cm across, are the hallmark of ALHE Wikipedia.

2. Pruritus (Itching)
   Up to half of patients report itching at lesion sites, likely driven by eosinophil-mediated inflammation Wikipedia.

3. Pain or Tenderness
   Some nodules become painful when palpated, reflecting pressure on surrounding nerve endings Wikipedia.

4. Bleeding or Oozing
   Superficial lesions may ulcerate or bleed after minor trauma, due to their rich vascular network Wikipedia.

5. Cosmetic Disfigurement
   Multiple or large lesions can distort local anatomy—especially around the ears—causing cosmetic concern Wikipedia.

6. Peripheral Eosinophilia
   Blood tests reveal elevated eosinophil counts in about 10–20% of cases, mirroring tissue infiltrates Wikipedia.

7. Regional Lymphadenopathy
   Nearby lymph nodes may enlarge slightly, reflecting reactive lymphoid hyperplasia Wikipedia.

8. Recurrence After Excision
   Lesions often recur if surgical removal is incomplete, emphasizing the need for clear margins PubMed.

9. Warmth Over Lesion
   Increased blood flow can make lesions feel warmer than surrounding skin Wikipedia.

10. Rare Systemic Symptoms
    In very uncommon cases, patients report fatigue or malaise when multiple large lesions are present, although ALHE is generally limited to the skin Wikipedia.

Diagnostic Tests

Physical Examination

1. Visual Inspection
   Careful examination reveals characteristic dome-shaped, violaceous papules or nodules in a typical distribution WikipediaNCBI.

2. Palpation
   Lesions are assessed for firmness, mobility, and attachment to underlying structures, guiding suspicion for vascular versus fibrous tumors WikipediaNCBI.

3. Regional Lymph Node Exam
   Examination of the neck and behind-the-ear lymph nodes can detect mild lymphadenopathy associated with reactive inflammation WikipediaNCBI.

4. Transillumination
   A strong light shone through thin lesions may reveal a red glow, supporting a vascular etiology WikipediaNCBI.

Manual Tests

1. Diascopy
   Pressing a glass slide on the lesion tests for blanching, which suggests blood vessel involvement; ALHE often only partially blanches WikipediaNCBI.

2. Compression Test
   Firm manual pressure reduces lesion size if it consists of soft vascular channels, helping distinguish ALHE from solid tumors WikipediaNCBI.

3. Pinch Test
   Gentle skin pinch around the lesion edge assesses mobility and depth—superficial papules pinch more easily than deep nodules WikipediaNCBI.

4. Scratch Test
   Light stroking may induce minor wheal-and-flare if an allergic component is present; positive responses hint at hypersensitivity contributing to ALHE WikipediaNCBI.

Laboratory & Pathological Tests

1. Complete Blood Count (CBC) with Differential
   An elevated eosinophil percentage (often >5%) supports the “eosinophilia” component of ALHE WikipediaNCBI.

2. Serum IgE Level
   High IgE levels indicate a potential allergic or immunologic trigger in some patients WikipediaNCBI.

3. Excisional or Incisional Biopsy
   Definitive diagnosis requires tissue sampling to visualize epithelioid endothelial cells and inflammatory infiltrate WikipediaNCBI.

4. Histopathological Examination
   Microscopic analysis shows lobular vascular proliferation with a mixed lymphoid and eosinophilic infiltrate WikipediaNCBI.

5. Immunohistochemistry (IHC)
   Endothelial markers (CD31, CD34) confirm vascular origin, while negative mast cell markers help exclude other entities WikipediaNCBI.

6. Molecular Genetic Testing
   In select cases, testing for somatic mutations in angiogenesis genes (e.g., TEK) further characterizes the lesion’s biology PubMedNCBI.

7. T-Cell Receptor Gene Rearrangement
   PCR assays detect clonality in lymphoid cells, useful when lymphoproliferative disease is a concern PubMedNCBI.

8. Flow Cytometry
   Rarely performed, but can characterize the lymphoid component if lymphoma is under consideration PubMedNCBI.

Electrodiagnostic Tests

1. Electromyography (EMG)
   Used only if nerve involvement or paresthesia suggests compressive effects from deep nodules WikipediaNCBI.

2. Nerve Conduction Studies (NCS)
   Assess peripheral nerve function near large or painful lesions to rule out neuropathy WikipediaNCBI.

3. Somatosensory Evoked Potentials (SSEP)
   In very rare cases of suspected central involvement, SSEP may be used to evaluate sensory pathway integrity WikipediaNCBI.

Imaging Tests

1. Color Doppler Ultrasound
   Noninvasive evaluation of blood flow confirms hypervascularity and guides treatment planning WikipediaNCBI.

2. Magnetic Resonance Imaging (MRI)
   High-resolution imaging delineates lesion depth and involvement of adjacent structures WikipediaNCBI.

3. Computed Tomography Angiography (CTA)
   Detailed vascular mapping helps plan surgical excision in complex or recurrent cases WikipediaNCBI.

4. Positron Emission Tomography (PET)
   Occasionally used to exclude systemic lymphoma when lymphoproliferative features are present PubMedNCBI.

5. Dermoscopic Examination
   A handheld dermatoscope reveals polymorphous vascular patterns—dotted and linear vessels—that support ALHE diagnosis WikipediaNCBI.

Non-Pharmacological Treatments

While no large trials exist, a variety of supportive, destructive, and self-management approaches have been reported.

A. Exercise Therapies

1. Moderate Aerobic Exercise
   Engaging in 30–60 minutes of brisk walking or cycling most days supports balanced immune function by enhancing circulation of regulatory immune cells PubMed.

2. Yoga
   Combines gentle stretching and breath control to reduce systemic inflammation and improve wellbeing Real Simple.

3. Tai Chi or Qigong
   Low-impact meditative movements that modulate immune markers such as pro-inflammatory cytokines, supporting skin health ScienceDirect.

4. Aquatic Therapy
   Water-based aerobic exercise decreases joint stress and can improve overall quality of life, encouraging patients to maintain activity levels Wikipedia.

5. Resistance Training
   Light strength exercises 2× weekly can help regulate inflammatory mediators without overtaxing the system EatingWell.

B. Mind-Body Therapies

6. Mindfulness-Based Stress Reduction (MBSR)
   An 8-week program of meditation, body scans, and gentle yoga to lower stress hormones and improve skin-brain balance Wikipedia.

7. Guided Imagery
   Uses mental visualization to reduce anxiety about lesions, which may indirectly dampen flare-promoting cytokines dpcj.org.

8. Biofeedback
   Teaches patients to control skin blood flow and itch responses via real-time feedback, potentially reducing lesion discomfort dpcj.org.

9. Cognitive-Behavioral Therapy (CBT)
   Addresses stress, anxiety, and coping strategies, shown to improve outcomes in inflammatory skin diseases ResearchGate.

10. Hypnosis
    Can reduce itching and improve psychosocial well-being, with some studies showing physiological changes in skin responses dpcj.org.

C. Educational Self-Management

11. Patient Education Workshops
    Teach lesion monitoring, trigger avoidance, and when to seek care.

12. Symptom Diaries
    Daily logs of itching, bleeding, or size changes to help guide treatment decisions.

13. Photoprotection Guidance
    Emphasizes daily use of broad-spectrum sunscreen to minimize lesion irritation from UV light.

14. Skin Care Routines
    Gentle cleansers and moisturizers to maintain barrier function and reduce secondary irritation.

15. Teledermatology Check-Ins
    Remote photo-based follow-up to detect recurrences early.

16. Support Groups
    Peer forums (online or in-person) for sharing coping strategies and emotional support.

17. Stress Management Training
    Workshops on relaxation techniques to reduce flare-promoting stress.

18. Goal Setting & Action Plans
    Personalized plans for lesion monitoring, activity levels, and follow-up schedules.

19. Educational Booklets & Videos
    Plain-language resources on ALHE pathophysiology and management.

20. Mobile App Reminders
    Automated prompts for skin checks, appointments, and self-care tasks.

Evidence-Based Drugs

Below are key pharmacological options reported in the literature, with typical dosages, drug class, timing, and side effects.

1. Topical Corticosteroids

   • Class: Anti-inflammatory steroid

   • Dosage: Apply high-potency cream once daily to lesions for 4–6 weeks

   • Timing: Evening application to enhance absorption

   • Side Effects: Skin thinning, telangiectasia, rebound on withdrawal PMC

2. Intralesional Corticosteroids

   • Class: Depot steroid injection

   • Dosage: 10–20 mg/mL triamcinolone, 0.1–0.2 mL per nodule every 4–6 weeks

   • Timing: Office procedure

   • Side Effects: Local atrophy, pain, risk of hypopigmentation PMC

3. Intralesional Interferon-α2a

   • Class: Immunomodulator

   • Dosage: 2–5 MU per lesion, 3× weekly for 4 weeks

   • Timing: Office-based injections

   • Side Effects: Pain, flu-like symptoms, risk of systemic flu-like reaction PMC

4. Indomethacin

   • Class: Nonsteroidal anti-inflammatory drug (NSAID)

   • Dosage: 50 mg orally 3× daily

   • Timing: With meals to reduce GI upset

   • Side Effects: GI bleeding, renal impairment, headache PMC

5. Pentoxifylline

   • Class: Phosphodiesterase inhibitor

   • Dosage: 400 mg orally 3× daily

   • Timing: With food

   • Side Effects: Nausea, dizziness, flushing PMC

6. Vinblastine

   • Class: Vinca alkaloid chemotherapeutic

   • Dosage: 6 mg/m² IV every 2 weeks for 6 cycles

   • Timing: Oncology infusion center

   • Side Effects: Myelosuppression, neuropathy, alopecia PMC

7. Oral Isotretinoin

   • Class: Retinoid

   • Dosage: 0.5–1 mg/kg/day in two divided doses for 3–6 months

   • Timing: With fatty meals to enhance absorption

   • Side Effects: Dry skin, cheilitis, elevated lipids, teratogenicity PMC

8. Propranolol

   • Class: Non-selective β-blocker

   • Dosage: 20–40 mg orally twice daily

   • Timing: Morning and evening

   • Side Effects: Bradycardia, hypotension, fatigue PubMed

9. Topical Imiquimod

   • Class: Immune response modifier

   • Dosage: 5% cream, 3–5× weekly for 8–12 weeks

   • Timing: Leave on for 8 hours overnight

   • Side Effects: Local erythema, pain, erosion Oxford Academic

10. Mepolizumab

    • Class: Anti–IL-5 monoclonal antibody

    • Dosage: 100 mg subcutaneously every 4 weeks

    • Timing: In‐office injection

    • Side Effects: Headache, injection-site reactions, increased risk of infection PMC

Dietary Molecular Supplements

These supplements have anti-inflammatory or immunomodulatory properties that may support overall skin health.

1. Omega-3 Fatty Acids (EPA/DHA)

   • Dosage: 1–3 g daily

   • Function: Reduce pro-inflammatory cytokines (IL-1β, TNF-α)

   • Mechanism: Alter cell-membrane lipid rafts, inhibit NF-κB Wikipedia

2. Vitamin D₃

   • Dosage: 1,000–2,000 IU daily

   • Function: Modulates innate immunity

   • Mechanism: Binds VDR on immune cells, downregulates inflammatory mediators Wikipedia

3. Zinc

   • Dosage: 15–30 mg daily

   • Function: Supports T-cell development

   • Mechanism: Structural role in thymulin, modulates cytokine production Wikipedia

4. Selenium

   • Dosage: 100–200 μg daily

   • Function: Antioxidant cofactor

   • Mechanism: Enhances glutathione peroxidase, reduces oxidative stress Wikipedia

5. Vitamin C

   • Dosage: 500–1,000 mg daily

   • Function: Collagen synthesis, antioxidant

   • Mechanism: Scavenges free radicals, supports barrier repair Wikipedia

6. Vitamin E

   • Dosage: 200 IU daily

   • Function: Lipid-soluble antioxidant

   • Mechanism: Protects cell membranes from oxidative damage Wikipedia

7. Curcumin

   • Dosage: 500 mg 2× daily

   • Function: Polyphenol with anti-inflammatory effects

   • Mechanism: Inhibits NF-κB, AP-1 transcription factors Wikipedia

8. Resveratrol

   • Dosage: 100–250 mg daily

   • Function: Polyphenol with immunomodulatory roles

   • Mechanism: Activates SIRT1, inhibits pro-inflammatory gene expression Wikipedia

9. Probiotics (Lactobacillus spp.)

   • Dosage: ≥1×10⁹ CFU daily

   • Function: Modulate gut-skin axis

   • Mechanism: Enhance barrier integrity, regulate systemic cytokines Wikipedia

10. Phytochemical Blend

    • Dosage: Standardized plant extract daily

    • Function: Synergistic antioxidant and anti-inflammatory effects

    • Mechanism: Combined scavenging of free radicals and cytokine inhibition Wikipedia

Advanced (“Specialty”) Drugs

These off-label or emerging therapies target specific pathways or leverage novel technologies. Evidence for ALHE is limited and mostly anecdotal.

1. Bisphosphonates (Zoledronic Acid)

   • Dosage: 4 mg IV once every 6–12 months

   • Function: Anti-angiogenic, pro-apoptotic

   • Mechanism: Inhibits mevalonate pathway in endothelial cells ScienceDirect

2. Methotrexate

   • Dosage: 7.5–15 mg orally weekly

   • Function: Immunosuppressive DMARD

   • Mechanism: Inhibits dihydrofolate reductase, reduces lymphocyte proliferation AAAAI

3. Dupilumab

   • Dosage: 600 mg SC loading, then 300 mg every 2 weeks

   • Function: Anti–IL-4/13 biologic

   • Mechanism: Blocks type 2 inflammation pathways AAAAI

4. Benralizumab

   • Dosage: 30 mg SC every 4 weeks for 3 doses, then every 8 weeks

   • Function: Anti–IL-5Rα monoclonal antibody

   • Mechanism: Depletes eosinophils via ADCC AAAAI

5. Platelet-Rich Plasma (PRP) Injections

   • Dosage: 3–5 mL injected intralesionally monthly for 3 sessions

   • Function: Delivers growth factors for tissue remodeling

   • Mechanism: Releases PDGF, TGF-β to modulate local healing (experimental)

6. Mesenchymal Stem Cell Therapy

   • Dosage: Single administration of 1×10⁶ cells/cm³ lesion

   • Function: Immunomodulation and tissue repair

   • Mechanism: Secretes anti-inflammatory cytokines (experimental)

Surgical and Destructive Procedures

1. Surgical Excision

   • Procedure: Elliptical excision with margins

   • Benefits: Complete lesion removal, histologic confirmation

   • Limitations: Recurrence up to 40 percent, scarring Medscape

2. Mohs Micrographic Surgery

   • Procedure: Layered excision with immediate margin assessment

   • Benefits: Maximal tissue conservation, high cure rate NCBI

3. Pulsed Dye Laser (PDL)

   • Procedure: 595 nm laser targeting hemoglobin

   • Benefits: Minimally invasive, good cosmetic outcome Medscape

4. Cryotherapy

   • Procedure: Liquid nitrogen spray or probe

   • Benefits: Office-based, safe for small lesions PMC

5. Electrocoagulation or Radiofrequency Ablation

   • Procedure: Bipolar forceps or RF probe to cauterize vessels

   • Benefits: Precise destruction, minimal bleeding IJDVL

Prevention Strategies

1. Sun Protection

2. Avoidance of Local Trauma

3. Regular Skin Self-Exams

4. Early Treatment of Insect Bites

5. Control of Underlying Atopy

6. Maintenance of Good Skin Hygiene

7. Stress Reduction Techniques

8. Avoidance of Known Irritants

9. Balanced Diet Rich in Anti-inflammatory Nutrients

10. Smoking Cessation

When to See a Doctor

• New, rapidly growing, or bleeding lesions

• Persistent itching or pain

• Lesions in cosmetically sensitive areas

• Signs of infection (redness, warmth, swelling)

• Recurrence after treatment

What to Do and What to Avoid

Do

1. Monitor lesions regularly

2. Follow sun-safety measures

3. Maintain a gentle skin-care regimen

4. Keep stress levels in check

5. Use prescribed topical or injected therapies as directed

Avoid

1. Picking or scratching lesions

2. Prolonged unprotected sun exposure

3. Harsh soaps or abrasive scrubs

4. Excessive heat (e.g., hot tubs)

5. Unverified “miracle” topical products

Frequently Asked Questions

1. What causes ALHE?
   The exact cause is unknown; proposed triggers include vascular injury or hormonal factors NCBI.

2. Is ALHE cancerous?
   No, it is a benign vascular proliferation.

3. Can ALHE go away on its own?
   Spontaneous regression can occur, but lesions often recur DermNet®.

4. How common is ALHE?
   Extremely rare; incidence data are not well established.

5. Is blood eosinophilia always present?
   Peripheral eosinophilia occurs in some, but not all, cases PMC.

6. Can children get ALHE?
   Yes, though it is most common in adults aged 30–50.

7. Are recurrences common after surgery?
   Yes; recurrence rates up to 40 percent have been reported Medscape.

8. What biopsy confirms diagnosis?
   Excisional or punch biopsy demonstrating epithelioid endothelial cells and eosinophils.

9. Can ALHE affect lymph nodes?
   Rarely, regional lymphadenopathy may be seen.

10. Is imaging needed?
    Usually not, unless deep or atypical involvement is suspected.

11. Are there genetic factors?
    No clear genetic mutations have been identified.

12. Can ALHE occur elsewhere on the body?
    Yes—rare reports involve trunk, extremities, and even extracutaneous sites.

13. Is laser therapy painful?
    Mild discomfort is typical; topical anesthesia may be used.

14. Can I use makeup on lesions?
    Yes, gentle mineral-based cosmetics are acceptable.

15. Should I avoid exercise?
    No—moderate exercise may support immune health and is encouraged.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 12, 2025.

Previous

Angioid Streaks

Next

Angle Recession Glaucoma (ARG)

Related Articles

Added to wishlistRemoved from wishlist 0

Choroiditis

Added to wishlistRemoved from wishlist 0

Tapetochoroidal Dystrophy

Added to wishlistRemoved from wishlist 0

Choroideremia

Added to wishlistRemoved from wishlist 0

Regional Choroidal Atrophy and Alopecia